Sarcomas

Latest News

sarcoma
Nirogacestat Significantly Reduces Pain Severity in Patients With Desmoid Tumors

June 4th 2023

Nirogacestat significantly reduced pain scores for patients with desmoid tumors.

Intermittent Dosing Strategy Helps Thrombocytopenia Related to MDM2 Inhibitor Milademetan
Intermittent Dosing Strategy Helps Thrombocytopenia Related to MDM2 Inhibitor Milademetan

April 23rd 2023

uterine carcinoma
Trastuzumab Deruxtecan Shows Promise as a Treatment for Patients With HER2+ Uterine Carcinosarcoma

April 7th 2023

© stock.adobe.com
Imatinib/Binimetinib Combo Shows Promising Responses in Treatment-Naïve GIST

February 8th 2022

Uterine Leiomyosarcoma
Olaparib Plus Temozolomide Induces Promising Response Duration in Uterine Leiomyosarcoma

January 8th 2022

Latest CME Events & Activities

C.R.U. Eye Symposium (Current, Relevant, Useful)

11/10/2023-11/12/2023

View More

C.R.U. Eye Symposium (Current, Relevant, Useful)

11/10/2023-11/12/2023

View More

C.R.U. Eye Symposium (Current, Relevant, Useful)

11/10/2023-11/12/2023

View More

Advances In™ Desmoid Tumors: Recognizing Disease Burden, Pathophysiology, and Targeted Treatments in Development

View More

BURST CME™: Taking ALS Management to the Next Level

View More

Taking Pompe Disease Management to the Next Level: Optimizing Clinical Assessments and Treatment Decision-Making

View More

7th Annual School of Nursing Oncology™

View More

Patient, Provider, and Caregiver Connection™: Incorporating the Patient Journey into HS Diagnosis and Management Practices

View More

The Latest on Acute Lymphocytic Leukemia

View More

A Focus on Acute Myeloid Leukemia

View More

Updates in Myelodysplastic Syndromes

View More

Patient, Provider, and Caregiver Connection™: Incorporating the Patient Journey into HS Diagnosis and Management Practices

View More

Patient, Provider, and Caregiver Connection™: Incorporating the Patient Journey into HS Diagnosis and Management Practices

View More

Clinical ConsultationsTM: Focusing on Fabry Disease in Females: Individualizing Diagnostic and Counseling Plans to Improve Long-Term Outcomes

View More

Patient, Provider, and Caregiver Connection: Addressing Pediatric and AYA Patient Concerns While Managing Hodgkin Lymphoma

View More

© 2023 MJH Life Sciences

All rights reserved.